Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 16 AL 30

Immunosenescence as a modifiable driver of neurodegenerative diseases: Pathways and multidimensional emerging strategies for Alzheimer's and Parkinson's diseases

Zhao J, Qu L, Guan H, Che H, Shi F, Yang Y.

Neurotherapeutics. 2026 Oct;23(6):e01096. doi: 10.1016/j.neurot.2026.e01096. Epub 2026 Oct 12.

Should ApoE4 gene editing therapy be approached with caution when AD is accompanied by retinal neurodegenerative diseases?

Wenhua Y, Wenjing M, Yan D, Fei L, Juan C, Xia T, Yu G, Xin L, Yanlin H, Ya G, Xuelin Y, Jing L, Meimin J, Wenyi L, Yilin K, Hongke L, Yating L.

Front Neurol. 2026 Oct 1;17:1934307. doi: 10.3389/fneur.2026.1934307. eCollection 2026.

Adaptation and feasibility of the International Registry for Alzheimer's Disease and Other Dementias real-world datasets in old-age mental healthcare practice in China

Zhang H, Lai J, Wang T, Li T, Liu S, Sun DL, Chen W, Kuang W, Li X, Zhang M, Liao Z, Xiang X, Tuerxun M, Zhang X, Zhang N, Xiao S, Jessen F, Yu E, Yu X, Wang H.

J Alzheimers Dis. 2026 Oct;113(3):1440-1448. doi: 10.1177/13872877261478137. Epub 2026 Aug 20.

Gut Microbiota in Alzheimer's Disease and Healthy Aging: Mechanisms, Prevention Strategies and Healthcare Burden

Çeli̇k MN, Mohammadzadeh M, Ahıskalı Öksüz M, Coşkun Us N, Ünlü Söğüt M.

Curr Nutr Rep. 2026 Oct 24;15(1):88. doi: 10.1007/s13668-026-00812-x.

Organizing healthcare delivery in the era of disease-modifying therapies for Alzheimer's Disease: an Italian RAND/UCLA consensus

Padovani A, Altini M, Bellelli G, Bozzali M, Brignoli O, Cagnin A, Cherubini A, Iannacci M, Lodi R, Logroscino G, Marra C, Nicora C, Parretti S, Sacco A, Spadin P, Zappia M.

Neurol Sci. 2026 Oct 9;47(11):850. doi: 10.1007/s10072-026-09452-z.

How can physicians empathetically deliver a diagnosis that reflects the evolving landscape of Alzheimer's disease care: A scoping review

Duhan A, Lu WH, Post S.

J Alzheimers Dis Rep. 2026 Oct 8;10:25424823261476636. doi: 10.1177/25424823261476636. eCollection 2026 Jan-Dec.

The Interplay Between Oophorectomy and Alzheimer's Disease: A Narrative Review

Xu S, Fu X, Zuo L, Wang M.

Medicina (Kaunas). 2026 Oct 21;62(10):2043. doi: 10.3390/medicina62102043.

Combating Alzheimer's through sleep and exercise (CASE): A study protocol

Chung D, Larsen BA, Garchitorena Gomez LG, Ramos AR, Kirk-Sanchez NJ, Jean-Louis G, Seixas AA.

Geroscience. 2026 Oct;48(5):6353-6374. doi: 10.1007/s11357-026-02337-1. Epub 2026 Jun 6.

Gingipains as macromolecular mediators at the periodontal-brain interface: Mechanistic, diagnostic, and therapeutic evidence in Alzheimer's and Parkinson's diseases

Dhar I, Gupta S, Mishra R, Dadhich A.

Int J Biol Macromol. 2026 Oct;377:153320. doi: 10.1016/j.ijbiomac.2026.153320. Epub 2026 Jul 2.

Neuroimaging in the era of biologically defined Alzheimer's disease and disease-modifying therapy

Benzinger TLS, Cogswell PM, Arani A, Chaney AM, Hutson K, Glasser MF, Graff-Radford J, McConathy J, Raji CA, Teunissen C, Vemuri P, Zaharchuk G, Jack CR Jr.

Lancet Neurol. 2026 Oct;25(10):939-951. doi: 10.1016/S1474-4422(26)00285-1.

Clinical pathways for cognitively unimpaired individuals with Alzheimer's disease neuropathological change

Graff-Radford J, Karliner L, Barnes DE, Frisoni GB, Sperling R, Villain N, Benzinger TLS, Teunissen C, Jack CR Jr.

Lancet Neurol. 2026 Oct;25(10):952-964. doi: 10.1016/S1474-4422(26)00248-6.

The complexities of diagnosing young-onset Alzheimer's dementia and the need for swift identification

Schild AK, Bartels C, Dodel R.

Expert Rev Neurother. 2026 Oct;26(10):923-941. doi: 10.1080/14737175.2026.2733193. Epub 2026 Sep 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias